跳至主要内容
临床试验/NCT03533166
NCT03533166已完成不适用

Clinical and Microbiological Effects of a 0.03% Chlorhexidine Mouth Rinse in the Prevention of Peri-implant Diseases: a Randomized Clinical Trial

Universidad Complutense de Madrid2 个研究点 分布在 1 个国家目标入组 54 人开始时间: 2015年11月4日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
54
试验地点
2
主要终点
Change on bleeding on probing on implants

研究概览

简要总结

Aim: To evaluate the efficacy of a 0.03% chlorhexidine (CHX) and 0.05% cetyl pyridinium chloride (CPC) mouth rinse, as an adjunct to professionally and patient-administered mechanical plaque removal, in the treatment of peri-implant mucositis.

Material and Methods: Patients displaying peri-implant mucositis in, at least, one implant were included in this randomized, double-blinded, clinical trial. Subjects received a conventional professional prophylaxis (at baseline and 6-month visits) and were instructed to regular oral hygiene practices and to rinse, twice daily, during one year, with a 0.03% CHX and 0.05% CPC mouth rinse, or a placebo. Clinical, radiographic and microbiological data were recorded at baseline, 6 and 12 months. Disease resolution was defined as the absence of bleeding on probing (BOP). Repeated measures ANOVA, Student-t and chi square tests were used.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

性别
All
接受健康志愿者

入选标准

  • the presence of, at least, one dental implant with clinical signs of peri-implant mucositis, defined as gently bleeding on probing (BOP) and/or suppuration without progressive radiographic bone loss (after at least 1 year of functional loading)

排除标准

  • untreated or recurrent periodontitis [presence of nine or more sites with PD 5 mm and with full mouth bleeding score (FMBS) > 25%];
  • implants affected by peri-implantitis, (BOP and/or suppuration and progressive radiographic bone loss);
  • removable implant-retained prosthesis;
  • history of intake of systemic antibiotics within the previous month or other chronic systemic medications that could interfere with the study outcomes;
  • and women being pregnant or breast-feeding.

研究组 & 干预措施

Placebo

Placebo Comparator

Mechanical treatment + Placebo mouth rinse

干预措施: Placebo (Other)

Chlorhexidine

Experimental

Mechanical treatment + 0.03% chlorhexidine + 0.05% CPC mouthrinse

干预措施: Chlorhexidine (Other)

结局指标

主要结局

Change on bleeding on probing on implants

时间窗: Change baseline-12 months

Bleeding on probing (BOP) on implants, evaluated dichotomously (presence/absence), considering a positive score when evident bleeding was observed within 15 s after gentle probing (Jepsen et al. 2015) at baseline, 3, 6, 9 and 12 months. Primary outcome would be considered for the change between baseline and 12 months One blinded and calibrated investigator recorded BOP at 6 sites around implants, using a plastic periodontal probe (PCV12, HuFriedy, Chicago, IL, USA) Calibration was achieved in double measurement calibration sessions, with a gold standard, on six randomly selected patients within one week. The inter-examiner agreement resulting in kappa (k) values of 0.78 for BOP).

次要结局

  • Plaque on teeth(12 months)
  • Probing depth on implants(12 months)
  • Crown-length implant(12 months)
  • Recession on teeth(12 months)
  • Microbiological outcomes_frequency of detection(12 months)
  • Bleeding on probing (BOP) on implants(12 months)
  • Bleeding on probing (BOP) on teeth(12 months)
  • Plaque on implants(12 months)
  • Probing depth on teeth(12 months)
  • Microbiological outcomes_proportions(12 months)
  • Microbiological outcomes_total counts(12 months)
  • Radiographic bone loss on implants(12 months)
  • Staining(12 months)
  • Adverse effect(12 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验